1-3 of 3
Thomas Krausgruber
Close
Sort by
Journal Articles

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

Gregory Ian Vladimer, PhD, Christian Schmidl, PhD, Andre Renderio, MS, Susanne Schnabl, MS, Tea Pemovska, PhD, Berend Snijder, PhD, Thomas Krausgruber, PhD, Nikolaus Krall, PhD, Mohammad Araghi, Rainer Hubmann, Anna Ringler, Dita Demirtas, Oscar Lopez de la Fuente, BSc, Martin Hilgrath, Cathrin Skrabs, MD, Edit Anna Porpaczy, MD, Michaela Gruber, MD PhD, Gregor Hoermann, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD, Medhat M. Shehata, MD, Giulio Superti-Furga, PhD, Christoph Bock, PhD, Ulrich Jaeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 800.
https://doi.org/10.1182/blood.V130.Suppl_1.800.800
Published: 2017
Journal Articles

Beyond the enhanceosome: cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation

Fui G. Goh, Scott J. P. Thomson, Thomas Krausgruber, Alessandra Lanfrancotti, Richard R. Copley, Irina A. Udalova
Journal: Blood
Blood (2010) 116 (25): 5580–5588.
https://doi.org/10.1182/blood-2010-05-282285
Published: 2010
Includes: Supplemental data
Journal Articles

IRF5 is required for late-phase TNF secretion by human dendritic cells

Thomas Krausgruber, David Saliba, Grigory Ryzhakov, Alessandra Lanfrancotti, Katrina Blazek, Irina A. Udalova
Journal: Blood
Blood (2010) 115 (22): 4421–4430.
https://doi.org/10.1182/blood-2010-01-263020
Published: 2010
Includes: Supplemental data